PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials ...
PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new webinar series exploring the latest innovations in ...
Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...
PhaseV's Adaptive Clinical Trials Platform Will Support the Gastrointestinal CRO in Addressing a Wide Range of GI-Related Conditions The collaboration has the potential to accelerate the ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials targeting gastrointestinal (GI) conditions. This collaboration ...